In vitro -assessment of putative antiprogestin activities of phytochemicals and synthetic UV absorbers in human endometrial Ishikawa cells

Gynecological Endocrinology

Volumn 31, Issue 7, 2015, Pages 578-581

  Yin, Qinan ^a   Fischer, Lara ^a   Noethling, Claudia ^a   Schaefer, Wolfgang R ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Endometrium; environmental antiprogestins; plant compounds; progesterone receptor; UV absorber

Indexed keywords

3 (4 METHYLBENZYLIDENE)CAMPHOR; 4 METHOXYCINNAMIC ACID 2 ETHYLHEXYL ESTER; APIGENIN; ESTROGEN SULFOTRANSFERASE; FERULIC ACID; MESSENGER RNA; MIFEPRISTONE; PROGESTERONE; ULIPRISTAL; CAMPHOR; COUMARIC ACID; ESTRONE SULFOTRANSFERASE; HORMONE ANTAGONIST; PLANT MEDICINAL PRODUCT; PREGNANE DERIVATIVE; PROGESTERONE RECEPTOR; SULFOTRANSFERASE; SUNSCREEN;

ANTIPROGESTIN ACTIVITY; ARTICLE; CELL ASSAY; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG POTENCY; DRUG RECEPTOR BINDING; EC50; ENDOMETRIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; ISHIKAWA CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSACTIVATION ASSAY; ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; ENDOMETRIUM; METABOLISM; TUMOR CELL LINE;

APIGENIN; CAMPHOR; CELL LINE, TUMOR; COUMARIC ACIDS; ENDOMETRIUM; FEMALE; HORMONE ANTAGONISTS; HUMANS; MIFEPRISTONE; NORPREGNADIENES; PHYTOCHEMICALS; RECEPTORS, PROGESTERONE; SULFOTRANSFERASES; SUNSCREENING AGENTS;

EID: 84940903203     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2015.1047448     Document Type: Article

References (23)

1. Strowitzki T, Germeyer A, Popovici R, von Wolff M. The human endometrium as a fertility-determining factor. Hum Reprod Update 2006; 12: 617-30.
2. Spitz IM. Clinical utility of progesterone receptor modulators and their effect on the endometrium. Curr Opin Obstet Gynecol 2009; 21: 318-24.
3. Elger W, Bartley J, Schneider B, et al. Endocrine pharmacological characterization of progesterone antagonists and progesterone receptor modulators with respect to PR-agonistic and antagonistic activity. Steroids 2000; 65: 713-23.
4. Scippo ML, Argiris C, Van De Weerdt C, et al. Recombinant human estrogen, androgen and progesterone receptors for detection of potential endocrine disruptors. Anal Bioanal Chem 2004; 378: 664-9.
5. Tran DQ, Klotz DM, Ladlie BL, et al. Inhibition of progesterone receptor activity in yeast by synthetic chemicals. Biochem Biophys Res Commun 1996; 229: 518-23.
6. Willemsen P, Scippo ML, Kausel G, et al. Use of reporter cell lines for detection of endocrine-disrupter activity. Anal Bioanal Chem 2004; 378: 655-63.
7. Fischer L, Deppert WR, Pfeifer D, et al. Potential hazards to embryo implantation: a human endometrial in vitro model to identify unwanted antigestagenic actions of chemicals. Toxicol Appl Pharmacol 2012; 260: 232-40.
8. Schreurs RH, Sonneveld E, Jansen JH, et al. Interaction of polycyclic musks and UV filters with the estrogen receptor (ER), androgen receptor (AR), and progesterone receptor (PR) in reporter gene bioassays. Toxicol Sci 2005; 83: 264-72.
9. Rosenberg RS, Grass L, Jenkins DJ, et al. Modulation of androgen and progesterone receptors by phytochemicals in breast cancer cell lines. Biochem Biophys Res Commun 1998; 248: 935-9.
10. Castelbaum AJ, Ying L, Somkuti SG, et al. Characterization of integrin expression in a well differentiated endometrial adenocarcinoma cell line (Ishikawa). J Clin Endocrinol Metab 1997; 82: 136-42.
11. Mo B, Vendrov AE, Palomino WA, et al. ECC-1 cells: a well-differentiated steroid-responsive endometrial cell line with characteristics of luminal epithelium. Biol Reprod 2006; 75: 387-94.
12. Hannan NJ, Paiva P, Dimitriadis E, Salamonsen LA. Models for study of human embryo implantation: choice of cell lines? Biol Reprod 2010; 82: 235-45.
13. Lessey BA, Ilesanmi AO, Castelbaum AJ, et al. Characterization of the functional progesterone receptor in an endometrial adenocarcinoma cell line (Ishikawa): progesterone-induced expression of the alpha1 integrin. J Steroid Biochem Mol Biol 1996; 59: 31-9.
14. Li A, Felix JC, Minoo P, et al. Effect of mifepristone on proliferation and apoptosis of Ishikawa endometrial adenocarcinoma cells. Fertil Steril 2005; 84: 202-11.
15. Pasqualini JR. Estrogen sulfotransferases in breast and endometrial cancers. Ann N Acad Sci 2009; 1155: 88-98.
16. Dassen H, Punyadeera C, Kamps R, et al. Estrogen metabolizing enzymes in endometrium and endometriosis. Hum Reprod 2007; 22: 3148-58.
17. Falany JL, Falany CN. Regulation of estrogen sulfotransferase in human endometrial adenocarcinoma cells by progesterone. Endocrinology 1996; 137: 1395-401.
18. Rubin GL, Harrold AJ, Mills JA, et al. Regulation of sulphotransferase expression in the endometrium during the menstrual cycle, by oral contraceptives and during early pregnancy. Mol Hum Reprod 1999; 5: 995-1002.
19. Schenk B, Weimer M, Bremer S, et al. The ReProTect Feasibility Study, a novel comprehensive in vitro approach to detect reproductive toxicants. Reprod Toxicol 2010; 30: 200-18.
20. Edwin S, Joshi SB, Jain DC. Antifertility activity of leaves of Plumbago zeylanica Linn. in female albino rats. Eur J Contracept Reprod Health Care 2009; 14: 233-9.
21. Pakrashi A, Shaha C. Effect of a sesquiterpene from Aristolochia indica Linn. on fertility in female mice. Experientia 1977; 33: 1498-9.
22. Vasudeva N, Sharma S. Post-coital antifertility activity of Hibiscus rosa-sinensis Linn. roots. Evid Based Complement Alternat Med 2008; 5: 91-4.
23. Kortenkamp A. Ten years of mixing cocktails: a review of combination effects of endocrine-disrupting chemicals. Environ Health Perspect 2007; 115 (Suppl. 1): 98-105.